(Q48760924)

15 February 2018

title

Ameliorating effects of RU 47213, a novel oral and long-lasting cholinomimetic agent, on working memory impairments in rats (English)

1 reference

15 February 2018

author name string

M'Harzi M

1

1 reference

15 February 2018

Willig F

2

1 reference

15 February 2018

Gieules C

3

1 reference

15 February 2018

Palou AM

4

1 reference

15 February 2018

Oberlander C

5

1 reference

15 February 2018

Barzaghi F

6

1 reference

15 February 2018

language of work or name

English

0 references

publication date

1 April 1997

1 reference

15 February 2018

Pharmacology, Biochemistry and Behavior

published in

1 reference

15 February 2018

volume

56

1 reference

15 February 2018

issue

4

1 reference

15 February 2018

page(s)

663-668

1 reference

15 February 2018

Scopolamine impairs recall of one-trial stimulus-reward association in monkeys

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900423-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900423-6

1 reference

7 January 2021

The cholinergic hypothesis of geriatric memory dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900423-6

7 January 2021

Modelling dementia: effects of scopolamine on memory and attention

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900423-6

7 January 2021

Radial maze as a tool for assessing the effect of drugs on the working memory of rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900423-6

7 January 2021

Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900423-6

7 January 2021

Effects of scopolamine, pentobarbital, and amphetamine on radial arm maze performance in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900423-6

7 January 2021

Effects of aging and dementia upon recent visuospatial memory.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900423-6

7 January 2021

Scopolamine effects on memory, language, visuospatial praxis and psychomotor speed.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900423-6

7 January 2021

Tacrine: A pharmacological review

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900423-6

7 January 2021

Cortical cholinergic fibers in aging and Alzheimer's disease: a morphometric study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900423-6

7 January 2021

Cholinergic 'blockade' as a model for cholinergic depletion. A comparison of the memory deficits with those of Alzheimer-type dementia and the alcoholic Korsakoff syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900423-6

7 January 2021

Differential effects of scopolamine on working and reference memory depend upon level of training

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900423-6

7 January 2021

Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900423-6

7 January 2021

Antagonism of scopolamine-induced memory impairments in rats by the muscarinic agonist RU 35,926 (CI-979).

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900423-6

7 January 2021

Reversal by tetrahydroaminoacridine of scopolamine-induced memory and performance deficits in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900423-6

7 January 2021

Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900423-6

7 January 2021

Emerging drugs for Alzheimer's disease. Mechanisms of action and prospects for cognitive enhancing medications.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900423-6

7 January 2021

Memory improvement without toxicity during chronic, low dose intravenous arecoline in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900423-6

7 January 2021

Short-term memory, exploration and locomotor activity in aged rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900423-6

7 January 2021

10.1016/S0091-3057(96)00423-6

Identifiers

DOI

1 reference

15 February 2018

1 reference

15 February 2018